ConductScience.org, home

Paper38332005

The scientific journey of a novel adjuvant (AS37) from bench to bedside.

D'Oro U and 1 other. NPJ Vaccines, 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. The scientific journey of a novel adjuvant (AS37) from bench to bedside. Papers, record 38332005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38332005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The scientific journey of a novel adjuvant (AS37) from bench to bedside.
PubMed
Journal
NPJ Vaccines
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.94, provisional
iCite
Revised in PubMed
2024-02-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Oro UUgohttps://orcid.org/0000-0002-7657-8605
2O'Hagan DTDerek T

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129801750Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.Semin Immunol2018https://conductscience.org/library/papers/29801750PubMed
233257234The continued advance of vaccine adjuvants - 'we can work it out'.Semin Immunol2020https://conductscience.org/library/papers/33257234PubMed
328855902Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.Front Immunol2017https://conductscience.org/library/papers/28855902PubMed
430850240Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.Vaccine2019https://conductscience.org/library/papers/30850240PubMed
533177181Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature.Sci Transl Med2020https://conductscience.org/library/papers/33177181PubMed
627236001Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.Clin Immunol2016https://conductscience.org/library/papers/27236001PubMed
734021167Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants.NPJ Vaccines2021https://conductscience.org/library/papers/34021167PubMed
836890168Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design.NPJ Vaccines2023https://conductscience.org/library/papers/36890168PubMed
936258023Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.Sci Rep2022https://conductscience.org/library/papers/36258023PubMed
1032845153Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.J Med Chem2020https://conductscience.org/library/papers/32845153PubMed
1126344622Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands.Vaccines (Basel)2014https://conductscience.org/library/papers/26344622PubMed
1233824489Emerging concepts in the science of vaccine adjuvants.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33824489PubMed
1336177016A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects.Front Immunol2022https://conductscience.org/library/papers/36177016PubMed
1430566863Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands.Cell Rep2018https://conductscience.org/library/papers/30566863PubMed
1526138638Bacterial RNA: An Underestimated Stimulus for Innate Immune Responses.J Immunol2015https://conductscience.org/library/papers/26138638PubMed
1620004021A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition.Mol Immunol2010https://conductscience.org/library/papers/20004021PubMed
1722587897Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains.Gene2012https://conductscience.org/library/papers/22587897PubMed
1815233738Modulating vaccine responses with dendritic cells and Toll-like receptors.Immunol Rev2004https://conductscience.org/library/papers/15233738PubMed
1931904601Toward precision adjuvants: optimizing science and safety.Curr Opin Pediatr2020https://conductscience.org/library/papers/31904601PubMed
2024910635Dendritic cell-targeted vaccines.Front Immunol2014https://conductscience.org/library/papers/24910635PubMed

See all 68 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42188770Lipid Nanoparticle-Encapsulated PolyI:C as an Adjuvant Enhances Both Humoral and Cellular Immune Responses to the Hepatitis B Vaccine.Vaccines (Basel)2026https://conductscience.org/library/papers/42188770PubMed
40918123Distinct effects of adjuvants on B cell responses to protein or polysaccharide antigens contained in glycoconjugate vaccines.Front Immunol2025https://conductscience.org/library/papers/40918123PubMed
40692104Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP).J Pharm Sci2025https://conductscience.org/library/papers/40692104PubMed
40536024Advances in vaccine adjuvant development and future perspectives.Drug Deliv2025https://conductscience.org/library/papers/40536024PubMed
40421643Development of a Recombinant Outer Membrane Vesicles (OMVs)-Based Vaccine Against Helicobacter pylori Infection in Mice.J Extracell Vesicles2025https://conductscience.org/library/papers/40421643PubMed
40281311TLR7-Adjuvanted Ionizable Lipid Nanoparticles for mRNA Vaccine Delivery.AAPS J2025https://conductscience.org/library/papers/40281311PubMed
39951545Linking vaccine adjuvant mechanisms of action to function.Sci Immunol2025https://conductscience.org/library/papers/39951545PubMed
39772007Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.Vaccines (Basel)2024https://conductscience.org/library/papers/39772007PubMed
39204028Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice.Vaccines (Basel)2024https://conductscience.org/library/papers/39204028PubMed
38932410Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant.Vaccines (Basel)2024https://conductscience.org/library/papers/38932410PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TLR751284PubTator's text mininghttps://conductscience.org/library/genes/51284

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38332005

GET https://conductscience.org/api/papers/v1/38332005/references?page=2